Sanj Patel
Vorstandsvorsitzender bei KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Vermögen: 32 Mio $ am 30.06.2024
Aktive Positionen von Sanj Patel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Vorstandsvorsitzender | 01.07.2015 | - |
Vorsitzender | 01.07.2015 | - | |
Gründer | 01.07.2015 | - | |
Sarcoma Foundation of America | Direktor/Vorstandsmitglied | 01.01.2015 | - |
Gründer | 01.01.2015 | - | |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Sanj Patel
Ehemalige bekannte Positionen von Sanj Patel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.09.2015 | 20.06.2018 |
Independent Dir/Board Member | 29.09.2015 | 20.06.2018 | |
SYROS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2016 | 14.06.2018 |
Independent Dir/Board Member | 01.05.2016 | 14.06.2018 | |
INTERCEPT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 17.02.2014 | 24.11.2015 |
Independent Dir/Board Member | 17.02.2014 | 24.11.2015 | |
SYNAGEVA BIOPHARMA CORP | Direktor/Vorstandsmitglied | 01.06.2008 | 22.06.2015 |
Vorstandsvorsitzender | 01.06.2008 | 22.06.2015 | |
Präsident | 01.06.2008 | 22.06.2015 | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.1999 | 01.01.2008 |
Ausbildung von Sanj Patel
London South Bank University | Undergraduate Degree |
Ealing Hammersmith & West London College | Graduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 6 |
Chief Executive Officer | 4 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Sarcoma Foundation of America | Miscellaneous |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Health Technology |
- Börse
- Insiders
- Sanj Patel
- Erfahrung